Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition

Core Insights - Exousia Pro, Inc. is accelerating its healthcare vertical through the execution of a third Letter of Intent to acquire a telehealth organization, enhancing its strategic position in the biotechnology sector [1][2]. Strategic Infrastructure & Direct-to-Patient Network - The acquisition of established telehealth platforms is a cornerstone of Exousia's strategy to create a vertically integrated health ecosystem, providing independent revenue streams and access to a built-in network of patients and providers [2]. - By utilizing its telehealth channels for marketing high-value clinical products, Exousia anticipates a significantly lower Customer Acquisition Cost (CAC), leading to higher margins and faster market penetration [2]. Specialized 3rd Acquisition: Institutional Scale - The target organization for the latest acquisition operates in a prestigious niche, collaborating with University-connected hospitals across the U.S. and has a proprietary model that can reduce hospital prescription costs by up to 50% [3]. The Revenue Model: Due Diligence & Timeline Update - Management is finalizing due diligence for the first two acquisitions, with the execution date pushed to later this month due to the thorough verification process aimed at ensuring long-term shareholder value [4]. - Due diligence materials for the third acquisition are currently under active review [4]. Leadership Perspective - The President of Exousia Pro, Inc. emphasized the aggressive scaling of healthcare infrastructure through targeted acquisitions, highlighting the significant standalone revenue and access to a high-intent audience for delivering cancer screening tests and nutraceuticals [5]. Proprietary Nutraceutical Products - Exousia Pro, Inc. focuses on advanced cancer screening tests and proprietary nutraceutical products, aiming to bridge the gap between clinical innovation and patient access through its expanding telehealth division [5][8]. Performance-Based Earnings - The company typically earns 10% of the total savings generated for hospitals over a four-year period, with most commissions realized within the first two years, ensuring robust and predictable cash flow [9].